Triple

T11145523
Position Surface form Disambiguated ID Type / Status
Subject pertuzumab E263659 entity
Predicate oftenUsedWith P4791 FINISHED
Object paclitaxel
Paclitaxel is a chemotherapy drug that stabilizes microtubules to inhibit cell division and is widely used to treat various cancers, including breast, ovarian, and lung cancers.
 E906737 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: paclitaxel | Statement: [pertuzumab, oftenUsedWith, paclitaxel]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: paclitaxel
Context triple: [pertuzumab, oftenUsedWith, paclitaxel]
  • A. docetaxel
    Docetaxel is a chemotherapy drug in the taxane class used to treat various cancers, including breast, lung, prostate, and gastric cancers, by inhibiting cell division.
  • B. Alimta
    Alimta is a chemotherapy drug (pemetrexed) primarily used to treat malignant pleural mesothelioma and non-small cell lung cancer.
  • C. Taxotere
    Taxotere is a chemotherapy medication containing docetaxel, commonly used to treat various cancers such as breast, lung, prostate, and gastric cancers.
  • D. irinotecan
    Irinotecan is a chemotherapy drug, specifically a topoisomerase I inhibitor, commonly used to treat colorectal and other cancers.
  • E. lapatinib
    Lapatinib is an oral small-molecule tyrosine kinase inhibitor used primarily to treat HER2-positive breast cancer.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: paclitaxel
Triple: [pertuzumab, oftenUsedWith, paclitaxel]
Generated description
Paclitaxel is a chemotherapy drug that stabilizes microtubules to inhibit cell division and is widely used to treat various cancers, including breast, ovarian, and lung cancers.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: paclitaxel
Target entity description: Paclitaxel is a chemotherapy drug that stabilizes microtubules to inhibit cell division and is widely used to treat various cancers, including breast, ovarian, and lung cancers.
  • A. docetaxel
    Docetaxel is a chemotherapy drug in the taxane class used to treat various cancers, including breast, lung, prostate, and gastric cancers, by inhibiting cell division.
  • B. Alimta
    Alimta is a chemotherapy drug (pemetrexed) primarily used to treat malignant pleural mesothelioma and non-small cell lung cancer.
  • C. Taxotere
    Taxotere is a chemotherapy medication containing docetaxel, commonly used to treat various cancers such as breast, lung, prostate, and gastric cancers.
  • D. irinotecan
    Irinotecan is a chemotherapy drug, specifically a topoisomerase I inhibitor, commonly used to treat colorectal and other cancers.
  • E. lapatinib
    Lapatinib is an oral small-molecule tyrosine kinase inhibitor used primarily to treat HER2-positive breast cancer.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aa9c0ba08190bbd19c217489b755 completed April 8, 2026, 7:21 p.m.
NER Named-entity recognition batch_69d7e8634d5481909b114d30a542ea3f completed April 9, 2026, 5:56 p.m.
NED1 Entity disambiguation (via context triple) batch_69e4421d35f48190a5905fbab39f4015 completed April 19, 2026, 2:46 a.m.
NEDg Description generation batch_69e44c0a9edc8190a184244ba63f1c8f completed April 19, 2026, 3:29 a.m.
NED2 Entity disambiguation (via description) batch_69e4513731fc8190be0bae62d1e16e6f completed April 19, 2026, 3:51 a.m.
Created at: April 8, 2026, 9:28 p.m.